BRAINLIFE.ORG





Topics


High-grade gliomas | Treatment | Radiotherapy | Margins






Home > Publications > Topics > High-grade gliomas > Treatment > Radiotherapy > Margins






Niitsu H, Fukumitsu N, Tanaka K, Mizumoto M, Nakai K, Matsuda M, Ishikawa E, Hatano K, Hashimoto T, Kamizawa S, Sakurai H.
Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma.
Ann Nucl Med. 2024 Feb 14. doi: 10.1007/s12149-024-01901-z. PMID: 38356008. Observational study. ˍ




Qiu Y, Li Y, Cuihong J, Wu X, Liu W, Fan C, Ye X, He L, Xiao S, Zhao Q, Wu W, Chen K, Tan C, Li Y, Wang H, Liu F.
Toxicity and Efficacy of Different Target Volume Delineations of Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in Patients with Grade 3-4 Glioma: A Randomized Controlled Clinical Trial.
Int J Radiat Oncol Biol Phys. 2024 Nov 28:S0360-3016(24)03668-X. doi: 10.1016/j.ijrobp.2024.11.094. PMID: 39615657. Interventional study˰ ˍ